March 5, 2019
FDA issues Safety Communication on using surgical robots in women’s health
Editor's Note
The Food and Drug Administration (FDA) on February 28 issued a Safety Communication on the safety and effectiveness of using robotically-assisted surgical devices in mastectomy procedures or in the prevention or treatment of cancer in women.
The FDA cited limited, preliminary evidence that the use of robotically-assisted surgical devices for treatment or prevention of cancers that primarily (breast) or exclusively (cervical) affect women may be linked to diminished long-term survival.
Free Daily News
- Acknowledging burnout can open discussion for improvement
- Mechanism found to boost muscle injury repair
- Federal program solicits autonomous robotic surgery technology proposals
- Financial hardships a reality for some after surgery
- Marburg virus disease outbreak in Ethiopia sparks alert for readiness in US
- OR Manager Welcomes New Content Director Joe Paone to Lead Brand Into Its Next Chapter
- Health access concerns up
- AI wound care monitor detects infections early
- Leaders need to build human-centered skills
- Trends in US outpatient surgery growth
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement